| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.802 | 0.003 | 0.802 | DNA directed RNA polymerase inhibitor | 0.116 0.04 CID_20662 | ||
| 0.644 | 0.004 | 0.644 | GABA C receptor rho-3 antagonist | 0.389 0.066 CID_20662 | ||
| 0.59 | 0.003 | 0.59 | Bruton tyrosine kinase inhibitor | |||
| 0.559 | 0.005 | 0.559 | ErbB-1 antagonist | |||
| 0.542 | 0.046 | 0.573 | Caspase 9 stimulant | 0.573 0.04 CID_20662 | CID_20662 | |
| 0.494 | 0.014 | 0.494 | Tumour necrosis factor alpha release inhibitor | |||
| 0.415 | 0.003 | 0.415 | MAP3K7 inhibitor | |||
| 0.431 | 0.04 | 0.497 | 5 Hydroxytryptamine release stimulant | 0.497 0.028 CID_20662 | CID_20662 | |
| 0.391 | 0.005 | 0.391 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.367 | 0.004 | 0.367 | Phosphodiesterase 4A inhibitor | |||
| 0.443 | 0.094 | 0.443 | Apoptosis agonist | |||
| 0.375 | 0.035 | 0.375 | Calcium channel activator | 0.368 0.039 CID_20662 | ||
| 0.349 | 0.012 | 0.472 | Alpha-N-acetylglucosaminidase inhibitor | 0.472 0.006 CID_20662 | CID_20662 | |
| 0.339 | 0.007 | 0.339 | GABA C receptor agonist | 0.179 0.025 CID_20662 | ||
| 0.331 | 0.005 | 0.331 | HIV-1 reverse transcriptase inhibitor | |||
| 0.349 | 0.026 | 0.349 | 5 Hydroxytryptamine uptake stimulant | 0.253 0.078 CID_20662 | ||
| 0.386 | 0.067 | 0.386 | Transcription factor NF kappa B inhibitor | |||
| 0.318 | 0.006 | 0.318 | Ferrochelatase inhibitor | 0.153 0.036 CID_20662 | ||
| 0.371 | 0.063 | 0.371 | Angiogenesis inhibitor | |||
| 0.309 | 0.004 | 0.309 | GABA C receptor antagonist | 0.183 0.017 CID_20662 | ||
| 0.303 | 0.005 | 0.303 | Janus tyrosine kinase 3 inhibitor | |||
| 0.329 | 0.043 | 0.329 | Insulysin inhibitor | 0.191 0.171 CID_20662 | ||
| 0.291 | 0.006 | 0.291 | GABA C receptor rho-2 antagonist | 0.163 0.058 CID_20662 | ||
| 0.315 | 0.034 | 0.356 | Peroxidase inhibitor | 0.356 0.027 CID_20662 | CID_20662 | |
| 0.324 | 0.043 | 0.324 | Superoxide dismutase inhibitor | 0.206 0.111 CID_20662 | ||
| 0.389 | 0.11 | 0.389 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.381 0.118 CID_20662 | ||
| 0.291 | 0.012 | 0.291 | Succinate dehydrogenase inhibitor | 0.228 0.031 CID_20662 | ||
| 0.276 | 0.006 | 0.276 | ErbB-4 antagonist | |||
| 0.293 | 0.036 | 0.293 | Tyrosine 3 hydroxylase inhibitor | 0.26 0.059 CID_20662 | ||
| 0.261 | 0.005 | 0.261 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.261 | 0.009 | 0.261 | Epidermal growth factor antagonist | |||
| 0.268 | 0.018 | 0.268 | MAP kinase kinase 3 inhibitor | |||
| 0.288 | 0.043 | 0.288 | Nitric oxide antagonist | |||
| 0.283 | 0.038 | 0.283 | Anesthetic general | 0.219 0.065 CID_20662 | ||
| 0.263 | 0.027 | 0.263 | Melanin inhibitor | 0.153 0.078 CID_20662 | ||
| 0.316 | 0.082 | 0.316 | Cholesterol antagonist | 0.308 0.086 CID_20662 | ||
| 0.256 | 0.024 | 0.256 | Phospholipase C inhibitor | 0.186 0.055 CID_20662 | ||
| 0.232 | 0.005 | 0.232 | GABA C receptor rho-1 antagonist | 0.114 0.046 CID_20662 | ||
| 0.275 | 0.05 | 0.275 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.314 | 0.09 | 0.345 | Vasodilator, peripheral | 0.345 0.076 CID_20662 | CID_20662 | |
| 0.233 | 0.009 | 0.233 | Porphobilinogen synthase inhibitor | 0.094 0.039 CID_20662 | ||
| 0.299 | 0.08 | 0.299 | 12-Lipoxygenase inhibitor | |||
| 0.272 | 0.056 | 0.272 | Gastrin inhibitor | 0.21 0.134 CID_20662 | ||
| 0.227 | 0.012 | 0.227 | Adenylate kinase inhibitor | 0.186 0.017 CID_20662 | ||
| 0.281 | 0.072 | 0.289 | Aldehyde oxidase inhibitor | 0.289 0.069 CID_20662 | CID_20662 | |
| 0.216 | 0.008 | 0.216 | TRPA1 agonist | |||
| 0.296 | 0.09 | 0.316 | Vasodilator, coronary | 0.316 0.075 CID_20662 | CID_20662 | |
| 0.252 | 0.048 | 0.313 | RNA-directed DNA polymerase inhibitor | 0.313 0.029 CID_20662 | CID_20662 | |
| 0.259 | 0.056 | 0.259 | Antimitotic | |||
| 0.21 | 0.007 | 0.21 | Prolactin inhibitor | 0.104 0.051 CID_20662 | ||
| 0.228 | 0.031 | 0.228 | Thiol protease inhibitor | 0.155 0.064 CID_20662 | ||
| 0.201 | 0.011 | 0.201 | Triose-phosphate isomerase inhibitor | 0.179 0.014 CID_20662 | ||
| 0.223 | 0.033 | 0.223 | 5 Hydroxytryptamine 3E antagonist | 0.217 0.04 CID_20662 | ||
| 0.202 | 0.013 | 0.202 | Adenylate cyclase stimulant | 0.15 0.063 CID_20662 | ||
| 0.205 | 0.019 | 0.205 | CF transmembrane conductance regulator agonist | 0.186 0.031 CID_20662 | ||
| 0.222 | 0.038 | 0.222 | Cytidine deaminase inhibitor | 0.203 0.046 CID_20662 | ||
| 0.249 | 0.067 | 0.348 | DNA synthesis inhibitor | 0.348 0.031 CID_20662 | CID_20662 | |
| 0.215 | 0.036 | 0.215 | Interferon gamma antagonist | 0.199 0.041 CID_20662 | ||
| 0.204 | 0.029 | 0.204 | Arachidonic acid antagonist | 0.186 0.047 CID_20662 | ||
| 0.179 | 0.004 | 0.179 | Fibroblast growth factor 4 antagonist | |||
| 0.177 | 0.003 | 0.177 | Exportin-1 inhibitor | 0.103 0.008 CID_20662 | ||
| 0.203 | 0.029 | 0.203 | Cell wall synthesis inhibitor | 0.181 0.039 CID_20662 | ||
| 0.186 | 0.02 | 0.288 | UDP-glucose 4-epimerase inhibitor | 0.288 0.011 CID_20662 | CID_20662 | |
| 0.177 | 0.012 | 0.177 | Glutamate dehydrogenase inhibitor | 0.132 0.019 CID_20662 | ||
| 0.176 | 0.011 | 0.176 | CYP2A6 inhibitor | 0.116 0.028 CID_20662 | ||
| 0.178 | 0.014 | 0.178 | Phosphofructokinase-1 inhibitor | 0.173 0.014 CID_20662 | ||
| 0.247 | 0.086 | 0.247 | Transcription factor STAT3 inhibitor | |||
| 0.163 | 0.003 | 0.163 | Dipeptidyl peptidase I inhibitor | 0.04 0.012 CID_20662 | ||
| 0.188 | 0.027 | 0.188 | Cystathionine beta-synthase inhibitor | 0.131 0.05 CID_20662 | ||
| 0.216 | 0.057 | 0.216 | Sigma receptor agonist | |||
| 0.17 | 0.013 | 0.171 | Ca2+-transporting ATPase inhibitor | 0.171 0.012 CID_20662 | CID_20662 | |
| 0.268 | 0.118 | 0.268 | Prostaglandin dehydrogenase inhibitor | 0.196 0.159 CID_20662 | ||
| 0.165 | 0.015 | 0.165 | ErbB-3 antagonist | |||
| 0.171 | 0.021 | 0.171 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.147 0.027 CID_20662 | ||
| 0.157 | 0.009 | 0.157 | Amidase inhibitor | |||
| 0.181 | 0.033 | 0.181 | Aldehyde dehydrogenase inhibitor | 0.12 0.071 CID_20662 | ||
| 0.211 | 0.065 | 0.211 | Tyrosine kinase inhibitor | |||
| 0.167 | 0.02 | 0.167 | Heat shock protein 70 antagonist | 0.142 0.068 CID_20662 | ||
| 0.2 | 0.054 | 0.2 | Tumour necrosis factor antagonist | |||
| 0.161 | 0.015 | 0.232 | NADH dehydrogenase inhibitor | 0.232 0.009 CID_20662 | CID_20662 | |
| 0.191 | 0.045 | 0.191 | ATPase inhibitor | 0.179 0.059 CID_20662 | ||
| 0.153 | 0.009 | 0.153 | Biliverdin reductase inhibitor | 0.106 0.017 CID_20662 | ||
| 0.228 | 0.086 | 0.228 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.187 | 0.046 | 0.187 | NOS3 expression enhancer | |||
| 0.149 | 0.009 | 0.149 | Acyl-CoA dehydrogenase inhibitor | 0.126 0.012 CID_20662 | ||
| 0.204 | 0.067 | 0.204 | I kappa B kinase epsilon inhibitor | 0.145 0.125 CID_20662 | ||
| 0.154 | 0.018 | 0.154 | Electrolyte absorption antagonist | |||
| 0.18 | 0.044 | 0.18 | Tubulin antagonist | |||
| 0.237 | 0.102 | 0.237 | Immunostimulant | 0.191 0.126 CID_20662 | ||
| 0.147 | 0.019 | 0.147 | Acetylcholine release stimulant | 0.114 0.058 CID_20662 | ||
| 0.147 | 0.02 | 0.147 | Anabolic | 0.127 0.033 CID_20662 | ||
| 0.128 | 0.003 | 0.128 | Dihydroorotate oxidase inhibitor | 0.076 0.013 CID_20662 | ||
| 0.136 | 0.016 | 0.136 | Ornithine decarboxylase inhibitor | 0.096 0.048 CID_20662 | ||
| 0.157 | 0.041 | 0.157 | Cathepsin H inhibitor | 0.154 0.043 CID_20662 | ||
| 0.132 | 0.017 | 0.132 | Glutamate decarboxylase inhibitor | 0.078 0.046 CID_20662 | ||
| 0.201 | 0.087 | 0.237 | Nitric-oxide synthase stimulant | 0.237 0.042 CID_20662 | CID_20662 | |
| 0.128 | 0.013 | 0.128 | Alcohol oxidase inhibitor | 0.125 0.013 CID_20662 | ||
| 0.134 | 0.019 | 0.169 | Lanosterol 14 alpha demethylase inhibitor | 0.169 0.007 CID_20662 | CID_20662 | |
| 0.232 | 0.117 | 0.247 | Hypoxia-inducible factor 1 alpha inhibitor | 0.247 0.104 CID_20662 | CID_20662 | |
| 0.289 | 0.178 | 0.434 | 5 Hydroxytryptamine release inhibitor | 0.434 0.059 CID_20662 | CID_20662 | |
| 0.139 | 0.028 | 0.139 | Breast cancer-resistant protein inhibitor | |||
| 0.128 | 0.017 | 0.128 | CDC25A inhibitor | |||
| 0.132 | 0.025 | 0.132 | MAP kinase kinase 1 inhibitor | 0.109 0.046 CID_20662 | ||
| 0.219 | 0.113 | 0.219 | Transcription factor STAT inhibitor | |||
| 0.146 | 0.04 | 0.163 | Microtubule formation inhibitor | 0.163 0.031 CID_20662 | CID_20662 | |
| 0.261 | 0.156 | 0.261 | 15-Lipoxygenase inhibitor | 0.219 0.193 CID_20662 | ||
| 0.116 | 0.012 | 0.117 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.117 0.011 CID_20662 | CID_20662 | |
| 0.12 | 0.016 | 0.12 | Janus tyrosine kinase 1 inhibitor | |||
| 0.163 | 0.06 | 0.163 | Protein kinase stimulant | 0.148 0.07 CID_20662 | ||
| 0.119 | 0.016 | 0.119 | GABA aminotransferase inhibitor | |||
| 0.116 | 0.014 | 0.117 | Glycine receptor agonist | 0.117 0.013 CID_20662 | CID_20662 | |
| 0.11 | 0.011 | 0.127 | Vanilloid 4 agonist | 0.127 0.005 CID_20662 | CID_20662 | |
| 0.129 | 0.03 | 0.151 | Calcium antagonist | 0.151 0.022 CID_20662 | CID_20662 | |
| 0.13 | 0.035 | 0.13 | DOPA decarboxylase inhibitor | 0.123 0.042 CID_20662 | ||
| 0.136 | 0.041 | 0.136 | Photosensitizer | 0.11 0.072 CID_20662 | ||
| 0.129 | 0.034 | 0.129 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.136 | 0.042 | 0.136 | MAP kinase kinase kinase inhibitor | |||
| 0.141 | 0.049 | 0.141 | Vanilloid 1 agonist | |||
| 0.191 | 0.1 | 0.191 | Cyclic AMP phosphodiesterase inhibitor | 0.182 0.109 CID_20662 | ||
| 0.225 | 0.137 | 0.225 | Caspase 3 stimulant | |||
| 0.111 | 0.024 | 0.111 | Glycine receptor antagonist | 0.085 0.049 CID_20662 | ||
| 0.1 | 0.013 | 0.1 | MAP kinase kinase 7 inhibitor | |||
| 0.129 | 0.043 | 0.129 | Xanthine oxidase inhibitor | 0.09 0.072 CID_20662 | ||
| 0.105 | 0.019 | 0.147 | Carbamoyl phosphate synthetase inhibitor | 0.147 0.011 CID_20662 | CID_20662 | |
| 0.094 | 0.009 | 0.094 | Transcription factor RelA inhibitor | 0.061 0.05 CID_20662 | ||
| 0.089 | 0.005 | 0.089 | Adenylate cyclase 1 inhibitor | |||
| 0.106 | 0.023 | 0.113 | Phenylalanine 4-hydroxylase inhibitor | 0.113 0.02 CID_20662 | CID_20662 | |
| 0.111 | 0.03 | 0.111 | Transcription factor NF kappa B stimulant | |||
| 0.09 | 0.01 | 0.09 | Aconitate hydratase inhibitor | 0.067 0.02 CID_20662 | ||
| 0.1 | 0.022 | 0.1 | Aromatase inhibitor | 0.064 0.039 CID_20662 | ||
| 0.095 | 0.017 | 0.095 | Ornithine carbamoyltransferase inhibitor | 0.063 0.029 CID_20662 | ||
| 0.108 | 0.031 | 0.108 | Glutathione S-transferase inhibitor | |||
| 0.227 | 0.15 | 0.227 | Thioredoxin glutathione reductase inhibitor | |||
| 0.118 | 0.042 | 0.118 | Creatine kinase inhibitor | 0.118 0.043 CID_20662 | ||
| 0.094 | 0.018 | 0.094 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.077 0.042 CID_20662 | ||
| 0.101 | 0.027 | 0.129 | Caspase 7 inhibitor | 0.129 0.012 CID_20662 | CID_20662 | |
| 0.092 | 0.018 | 0.092 | Androgen agonist | 0.091 0.018 CID_20662 | ||
| 0.078 | 0.005 | 0.078 | Dopamine beta hydroxylase inhibitor | |||
| 0.141 | 0.068 | 0.141 | Amylase inhibitor | 0.14 0.069 CID_20662 | ||
| 0.097 | 0.025 | 0.097 | CC chemokine 5 receptor agonist | 0.078 0.073 CID_20662 | ||
| 0.081 | 0.008 | 0.117 | Glucose-6-phosphate isomerase inhibitor | 0.117 0.004 CID_20662 | CID_20662 | |
| 0.08 | 0.008 | 0.091 | Potassium channel (Inward rectifier) activator | 0.091 0.005 CID_20662 | CID_20662 | |
| 0.083 | 0.011 | 0.083 | Potassium channel Kv1.3 blocker | 0.042 0.039 CID_20662 | ||
| 0.113 | 0.042 | 0.118 | Interleukin 1 beta converting enzyme inhibitor | 0.118 0.037 CID_20662 | CID_20662 | |
| 0.112 | 0.042 | 0.112 | Protein kinase C delta inhibitor | |||
| 0.248 | 0.178 | 0.29 | Antibacterial | 0.29 0.143 CID_20662 | CID_20662 | |
| 0.077 | 0.007 | 0.089 | Potassium channel (ATP-sensitive) activator | 0.089 0.005 CID_20662 | CID_20662 | |
| 0.134 | 0.065 | 0.134 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.102 | 0.035 | 0.102 | Inducible nitric-oxide synthase inhibitor | |||
| 0.172 | 0.105 | 0.172 | Insulin sensitizer | |||
| 0.068 | 0.005 | 0.068 | Kainate receptor agonist | 0.043 0.024 CID_20662 | ||
| 0.17 | 0.107 | 0.283 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.283 0.029 CID_20662 | CID_20662 | |
| 0.219 | 0.155 | 0.219 | Antithrombotic | |||
| 0.097 | 0.034 | 0.097 | Na+ K+ transporting ATPase inhibitor | 0.096 0.035 CID_20662 | ||
| 0.102 | 0.04 | 0.102 | Glutamate release inhibitor | 0.1 0.043 CID_20662 | ||
| 0.067 | 0.007 | 0.067 | Potassium channel Kv1.1 blocker | 0.036 0.031 CID_20662 | ||
| 0.129 | 0.069 | 0.129 | Toll-Like receptor 2 antagonist | |||
| 0.103 | 0.045 | 0.103 | Androgen antagonist | 0.086 0.059 CID_20662 | ||
| 0.114 | 0.058 | 0.139 | Falcipain 3 inhibitor | 0.139 0.042 CID_20662 | CID_20662 | |
| 0.074 | 0.019 | 0.074 | Protein kinase C theta inhibitor | 0.054 0.047 CID_20662 | ||
| 0.112 | 0.057 | 0.124 | Expectorant | 0.124 0.048 CID_20662 | CID_20662 | |
| 0.069 | 0.015 | 0.069 | Lysophosphatidic acid 3 receptor antagonist | 0.046 0.043 CID_20662 | ||
| 0.129 | 0.077 | 0.129 | Alkaline phosphatase inhibitor | |||
| 0.079 | 0.027 | 0.079 | 5 Hydroxytryptamine 3 agonist | |||
| 0.061 | 0.009 | 0.061 | Membrane dipeptidase inhibitor | 0.036 0.033 CID_20662 | ||
| 0.078 | 0.026 | 0.078 | TRPA1 antagonist | |||
| 0.078 | 0.026 | 0.078 | Glutamate (mGluR6) antagonist | 0.077 0.028 CID_20662 | ||
| 0.062 | 0.011 | 0.062 | Dihydropteroate synthase inhibitor | |||
| 0.159 | 0.108 | 0.159 | Pyruvate kinase inhibitor | |||
| 0.123 | 0.071 | 0.123 | MAP kinase kinase inhibitor | |||
| 0.085 | 0.035 | 0.085 | Calcium channel L-type blocker | |||
| 0.057 | 0.007 | 0.057 | Cathepsin F inhibitor | 0.041 0.03 CID_20662 | ||
| 0.117 | 0.067 | 0.117 | Cholesterol synthesis inhibitor | |||
| 0.09 | 0.04 | 0.095 | Estrogen-related receptor beta agonist | 0.095 0.032 CID_20662 | CID_20662 | |
| 0.083 | 0.035 | 0.083 | Sphingosine 1-phosphate receptor 4 agonist | 0.074 0.042 CID_20662 | ||
| 0.086 | 0.039 | 0.086 | Histidine decarboxylase inhibitor | 0.078 0.044 CID_20662 | ||
| 0.076 | 0.031 | 0.076 | NMDA receptor glycine site agonist | |||
| 0.158 | 0.114 | 0.158 | MAP kinase kinase 2 inhibitor | |||
| 0.062 | 0.018 | 0.093 | Aldosterone antagonist | 0.093 0.009 CID_20662 | CID_20662 | |
| 0.092 | 0.048 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.055 CID_20662 | ||
| 0.068 | 0.026 | 0.068 | Prolactin release inhibitor | |||
| 0.222 | 0.179 | 0.222 | Histamine release inhibitor | 0.206 0.195 CID_20662 | ||
| 0.098 | 0.056 | 0.098 | Phosphodiesterase 6D inhibitor | |||
| 0.124 | 0.082 | 0.124 | Toll-Like receptor 9 antagonist | |||
| 0.068 | 0.027 | 0.078 | Fatty acid synthase inhibitor | 0.078 0.019 CID_20662 | CID_20662 | |
| 0.135 | 0.094 | 0.135 | MAP kinase 3 inhibitor | |||
| 0.085 | 0.045 | 0.085 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.1 | 0.06 | 0.1 | Nitric-oxide synthase inhibitor | |||
| 0.049 | 0.009 | 0.049 | Vanilloid 3 antagonist | 0.045 0.013 CID_20662 | ||
| 0.148 | 0.107 | 0.148 | Neurotensin receptor agonist | |||
| 0.117 | 0.077 | 0.117 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.147 | 0.107 | 0.147 | DNA methyltransferase I inhibitor | |||
| 0.08 | 0.042 | 0.08 | Aminopeptidase I inhibitor | 0.076 0.046 CID_20662 | ||
| 0.051 | 0.013 | 0.051 | Fumarate hydratase inhibitor | 0.05 0.013 CID_20662 | ||
| 0.19 | 0.151 | 0.19 | Lipoxygenase inhibitor | |||
| 0.047 | 0.009 | 0.047 | Uridine phosphorylase inhibitor | 0.044 0.01 CID_20662 | ||
| 0.05 | 0.012 | 0.05 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.161 | 0.124 | 0.161 | Histone acetyltransferase inhibitor | |||
| 0.106 | 0.07 | 0.139 | Mucolytic | 0.139 0.039 CID_20662 | CID_20662 | |
| 0.107 | 0.071 | 0.107 | Monophenol monooxygenase inhibitor | |||
| 0.082 | 0.046 | 0.082 | Keratolytic | 0.08 0.048 CID_20662 | ||
| 0.087 | 0.051 | 0.087 | D-Ala-D-Ala ligase inhibitor | 0.086 0.053 CID_20662 | ||
| 0.066 | 0.031 | 0.066 | Cathepsin B inhibitor | |||
| 0.062 | 0.028 | 0.069 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.069 0.022 CID_20662 | CID_20662 | |
| 0.047 | 0.014 | 0.047 | Glutamate (mGluR8) agonist | 0.039 0.025 CID_20662 | ||
| 0.063 | 0.03 | 0.063 | Ryanodine receptor antagonist | |||
| 0.115 | 0.083 | 0.126 | Cyclooxygenase 3 inhibitor | 0.126 0.07 CID_20662 | CID_20662 | |
| 0.144 | 0.112 | 0.211 | 3C-like protease (Human coronavirus) inhibitor | 0.211 0.046 CID_20662 | CID_20662 | |
| 0.07 | 0.038 | 0.07 | MDM2 inhibitor | 0.067 0.049 CID_20662 | ||
| 0.13 | 0.099 | 0.137 | Pregnane X receptor agonist | 0.137 0.08 CID_20662 | CID_20662 | |
| 0.08 | 0.049 | 0.08 | Estrogen receptor alpha antagonist | |||
| 0.047 | 0.017 | 0.06 | Heme oxygenase inhibitor | 0.06 0.006 CID_20662 | CID_20662 | |
| 0.064 | 0.034 | 0.086 | Argininosuccinate synthase inhibitor | 0.086 0.023 CID_20662 | CID_20662 | |
| 0.106 | 0.077 | 0.106 | Anesthetic local | |||
| 0.046 | 0.016 | 0.046 | Retinoid X receptor antagonist | |||
| 0.107 | 0.078 | 0.107 | Proteasome inhibitor | |||
| 0.124 | 0.095 | 0.202 | Mannose-6-phosphate isomerase inhibitor | 0.202 0.029 CID_20662 | CID_20662 | |
| 0.038 | 0.009 | 0.038 | Nicotinic alpha4beta2 receptor agonist | 0.027 0.023 CID_20662 | ||
| 0.157 | 0.128 | 0.164 | Neurotrophic factor enhancer | 0.164 0.118 CID_20662 | CID_20662 | |
| 0.068 | 0.039 | 0.068 | Protease 3C (Human rhinovirus) inhibitor | 0.068 0.039 CID_20662 | ||
| 0.229 | 0.202 | 0.229 | Transcription factor inhibitor | |||
| 0.096 | 0.068 | 0.13 | Glutamate (mGluR7) agonist | 0.13 0.022 CID_20662 | CID_20662 | |
| 0.049 | 0.022 | 0.075 | Guanylate cyclase inhibitor | 0.075 0.004 CID_20662 | CID_20662 | |
| 0.041 | 0.014 | 0.041 | Retinoid X alpha receptor antagonist | |||
| 0.039 | 0.013 | 0.039 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.032 | 0.007 | 0.032 | Vanilloid 2 agonist | 0.026 0.016 CID_20662 | ||
| 0.094 | 0.069 | 0.094 | Aminopeptidase B inhibitor | 0.088 0.074 CID_20662 | ||
| 0.065 | 0.041 | 0.065 | NMDA receptor agonist | |||
| 0.044 | 0.021 | 0.044 | Progesterone antagonist | |||
| 0.027 | 0.005 | 0.027 | Retinoid X beta receptor antagonist | |||
| 0.045 | 0.023 | 0.045 | Thymidine kinase inhibitor | 0.039 0.031 CID_20662 | ||
| 0.032 | 0.01 | 0.032 | Nicotinic acid receptor 2 antagonist | |||
| 0.073 | 0.052 | 0.083 | Catalase inhibitor | 0.083 0.046 CID_20662 | CID_20662 | |
| 0.044 | 0.023 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.087 | 0.065 | 0.087 | Potassium channel activator | 0.087 0.064 CID_20662 | ||
| 0.06 | 0.039 | 0.06 | Cathepsin L inhibitor | 0.054 0.046 CID_20662 | ||
| 0.029 | 0.009 | 0.029 | Complement factor 1s inhibitor | |||
| 0.064 | 0.044 | 0.068 | Calcium channel P-type blocker | 0.068 0.033 CID_20662 | CID_20662 | |
| 0.026 | 0.007 | 0.026 | Factor XIII inhibitor | |||
| 0.057 | 0.038 | 0.057 | Pregnane X receptor antagonist | 0.057 0.038 CID_20662 | ||
| 0.043 | 0.024 | 0.043 | Dopamine D5 agonist | |||
| 0.036 | 0.018 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.04 | 0.022 | 0.04 | Retinoid X receptor agonist | |||
| 0.034 | 0.015 | 0.04 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.04 0.012 CID_20662 | CID_20662 | |
| 0.049 | 0.031 | 0.058 | Adenosine deaminase inhibitor | 0.058 0.023 CID_20662 | CID_20662 | |
| 0.179 | 0.161 | 0.191 | Neuropeptide Y2 antagonist | 0.191 0.136 CID_20662 | CID_20662 | |
| 0.025 | 0.008 | 0.025 | Neuraminidase (Influenza B) inhibitor | |||
| 0.042 | 0.024 | 0.042 | GABA uptake inhibitor | |||
| 0.048 | 0.031 | 0.048 | CC chemokine 4 receptor antagonist | 0.046 0.035 CID_20662 | ||
| 0.038 | 0.021 | 0.038 | Retinoid X alpha receptor agonist | |||
| 0.039 | 0.023 | 0.039 | Kainate receptor 2 antagonist | |||
| 0.045 | 0.029 | 0.045 | Geranyltranstransferase inhibitor | |||
| 0.111 | 0.096 | 0.111 | Antibacterial (Helicobacter pylori) | |||
| 0.044 | 0.029 | 0.044 | Histamine H2 receptor agonist | |||
| 0.05 | 0.035 | 0.05 | Squalene epoxidase inhibitor | 0.049 0.036 CID_20662 | ||
| 0.028 | 0.014 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 CID_20662 | ||
| 0.053 | 0.038 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.037 | 0.023 | 0.053 | Phosphoglycerate kinase inhibitor | 0.053 0.013 CID_20662 | CID_20662 | |
| 0.069 | 0.055 | 0.069 | Phospholipase D inhibitor | |||
| 0.023 | 0.009 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.019 0.018 CID_20662 | ||
| 0.041 | 0.028 | 0.041 | Cathepsin L2 inhibitor | |||
| 0.055 | 0.042 | 0.055 | Xanthine dehydrogenase inhibitor | |||
| 0.048 | 0.035 | 0.048 | HCV NS3/NS4A protease inhibitor | |||
| 0.032 | 0.019 | 0.032 | Nicotinic alpha3beta4 receptor agonist | 0.03 0.021 CID_20662 | ||
| 0.03 | 0.017 | 0.032 | MAP3K8 inhibitor | 0.032 0.014 CID_20662 | CID_20662 | |
| 0.039 | 0.027 | 0.039 | 5 Hydroxytryptamine 2B agonist | |||
| 0.098 | 0.086 | 0.098 | Adenylate cyclase inhibitor | |||
| 0.063 | 0.052 | 0.077 | Acetylcholine M5 receptor agonist | 0.077 0.037 CID_20662 | CID_20662 | |
| 0.026 | 0.015 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.019 | 0.008 | 0.019 | Nicotinic alpha4 receptor agonist | |||
| 0.024 | 0.014 | 0.025 | Prostaglandin F2 alpha agonist | 0.025 0.012 CID_20662 | CID_20662 | |
| 0.033 | 0.023 | 0.033 | Estrogen-related receptor alpha antagonist | |||
| 0.022 | 0.012 | 0.022 | Imidazoline I1 receptor antagonist | 0.02 0.015 CID_20662 | ||
| 0.037 | 0.027 | 0.037 | Factor XIIIa inhibitor | |||
| 0.027 | 0.018 | 0.027 | Retinoid X gamma receptor antagonist | |||
| 0.038 | 0.029 | 0.038 | Cathepsin L1 inhibitor | |||
| 0.1 | 0.091 | 0.1 | Caspase 3 inhibitor | |||
| 0.064 | 0.055 | 0.064 | Glutamate (mGluR7) antagonist | 0.063 0.057 CID_20662 | ||
| 0.039 | 0.03 | 0.06 | Glutamate (mGluR1a) antagonist | 0.06 0.015 CID_20662 | CID_20662 | |
| 0.09 | 0.081 | 0.09 | Mediator release inhibitor | |||
| 0.028 | 0.02 | 0.036 | Purinergic P2Y15 antagonist | 0.036 0.009 CID_20662 | CID_20662 | |
| 0.083 | 0.075 | 0.083 | Alcohol dehydrogenase inhibitor | |||
| 0.081 | 0.073 | 0.081 | Bromodomain-containing protein 2 inhibitor | |||
| 0.051 | 0.043 | 0.051 | Lysine-specific demethylase 1A inhibitor | |||
| 0.08 | 0.072 | 0.08 | Vanilloid agonist | |||
| 0.05 | 0.042 | 0.05 | Dipeptidyl peptidase inhibitor | |||
| 0.123 | 0.117 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.056 | 0.05 | 0.075 | Purinergic P2X1 antagonist | 0.075 0.028 CID_20662 | CID_20662 | |
| 0.058 | 0.052 | 0.058 | Dopamine D1 antagonist | |||
| 0.019 | 0.013 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.035 | 0.029 | 0.035 | Diamine oxidase inhibitor | |||
| 0.113 | 0.107 | 0.123 | Nav1.6 sodium channel blocker | 0.123 0.091 CID_20662 | CID_20662 | |
| 0.018 | 0.013 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.01 CID_20662 | CID_20662 | |
| 0.018 | 0.014 | 0.018 | Alpha 2c adrenoreceptor agonist | |||
| 0.041 | 0.037 | 0.041 | Dihydroorotase inhibitor | |||
| 0.024 | 0.02 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 CID_20662 | ||
| 0.04 | 0.037 | 0.04 | Oleamide hydrolase inhibitor | |||
| 0.026 | 0.023 | 0.031 | Hedgehog signaling activator | 0.031 0.012 CID_20662 | CID_20662 | |
| 0.082 | 0.079 | 0.108 | Uric acid excretion stimulant | 0.108 0.046 CID_20662 | CID_20662 | |
| 0.053 | 0.05 | 0.054 | Leukotriene C antagonist | 0.054 0.049 CID_20662 | CID_20662 | |
| 0.091 | 0.088 | 0.091 | 5 Hydroxytryptamine 3A agonist | |||
| 0.016 | 0.014 | 0.022 | Telomerase stimulant | 0.022 0.006 CID_20662 | CID_20662 | |
| 0.057 | 0.055 | 0.057 | Heme oxygenase stimulant | |||
| 0.049 | 0.047 | 0.074 | Alpha-mannosidase inhibitor | 0.074 0.014 CID_20662 | CID_20662 | |
| 0.015 | 0.013 | 0.016 | Carbonic anhydrase X inhibitor | 0.016 0.012 CID_20662 | CID_20662 | |
| 0.015 | 0.013 | 0.016 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 CID_20662 | CID_20662 | |
| 0.024 | 0.023 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 CID_20662 | CID_20662 | |
| 0.012 | 0.011 | 0.024 | Lysophosphatidic acid receptor 3 agonist | 0.024 0.004 CID_20662 | CID_20662 | |
| 0.045 | 0.044 | 0.064 | Prolyl endopeptidase inhibitor | 0.064 0.02 CID_20662 | CID_20662 | |
| 0.032 | 0.031 | 0.036 | Inosine monophosphate dehydrogenase inhibitor | 0.036 0.026 CID_20662 | CID_20662 | |
| 0.029 | 0.028 | 0.029 | ATP citrate lysase inhibitor | |||
| 0.049 | 0.049 | 0.067 | Sphingosine kinase 2 inhibitor | 0.067 0.024 CID_20662 | CID_20662 | |
| 0.068 | 0.069 | 0.09 | Potassium channel (Tandem pore domain) blocker | 0.09 0.017 CID_20662 | CID_20662 | |
| 0.158 | 0.159 | 0.171 | Interleukin agonist | 0.171 0.148 CID_20662 | CID_20662 | |
| 0.052 | 0.054 | 0.067 | Alpha 2 adrenoreceptor agonist | 0.067 0.035 CID_20662 | CID_20662 | |
| 0.018 | 0.023 | 0.022 | Geranylgeranyltransferase inhibitor | 0.022 0.016 CID_20662 | CID_20662 | |
| 0.012 | 0.019 | 0.019 | Purinergic P2Y1 agonist | 0.019 0.007 CID_20662 | CID_20662 | |
| 0.019 | 0.027 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_20662 | CID_20662 | |
| 0.016 | 0.024 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_20662 | CID_20662 | |
| 0.11 | 0.118 | 0.121 | Diuretic | 0.121 0.104 CID_20662 | CID_20662 | |
| 0.043 | 0.053 | 0.076 | Acetylcholine muscarinic agonist | 0.076 0.024 CID_20662 | CID_20662 | |
| 0.021 | 0.034 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.017 CID_20662 | CID_20662 | |
| 0.079 | 0.094 | 0.088 | Carbonic anhydrase III inhibitor | 0.088 0.077 CID_20662 | CID_20662 | |
| 0.035 | 0.05 | 0.062 | Mannosidase inhibitor | 0.062 0.016 CID_20662 | CID_20662 | |
| 0.012 | 0.028 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.018 0.015 CID_20662 | CID_20662 | |
| 0.057 | 0.075 | 0.08 | Cathepsin G inhibitor | 0.08 0.044 CID_20662 | CID_20662 | |
| 0.029 | 0.048 | 0.052 | Vascular adhesion protein 1 inhibitor | 0.052 0.014 CID_20662 | CID_20662 | |
| 0.062 | 0.082 | 0.082 | Macrophage migration inhibitory factor inhibitor | 0.082 0.049 CID_20662 | CID_20662 | |
| 0.01 | 0.032 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.012 CID_20662 | CID_20662 | |
| 0.058 | 0.08 | 0.094 | Secretase beta inhibitor | 0.094 0.022 CID_20662 | CID_20662 | |
| 0.111 | 0.134 | 0.124 | Hemostatic | 0.124 0.105 CID_20662 | CID_20662 | |
| 0.029 | 0.053 | 0.046 | Acetylcholine M1 receptor agonist | 0.046 0.028 CID_20662 | CID_20662 | |
| 0.01 | 0.035 | 0.033 | Cyclin T1 inhibitor | 0.033 0.004 CID_20662 | CID_20662 | |
| 0.023 | 0.049 | 0.032 | Free fatty acid receptor 1 antagonist | 0.032 0.026 CID_20662 | CID_20662 | |
| 0.039 | 0.069 | 0.054 | Cytokine production stimulant | 0.054 0.02 CID_20662 | CID_20662 | |
| 0.049 | 0.079 | 0.064 | Beta adrenoreceptor antagonist | 0.064 0.048 CID_20662 | CID_20662 | |
| 0.035 | 0.066 | 0.052 | Potassium channel (Inward rectifier) blocker | 0.052 0.031 CID_20662 | CID_20662 | |
| 0.038 | 0.069 | 0.055 | Beta 1 adrenoreceptor antagonist | 0.055 0.041 CID_20662 | CID_20662 | |
| 0.009 | 0.042 | 0.022 | Cathepsin S inhibitor | 0.022 0.011 CID_20662 | CID_20662 | |
| 0.031 | 0.073 | 0.047 | GABA B receptor antagonist | 0.047 0.024 CID_20662 | CID_20662 | |
| 0.104 | 0.146 | 0.141 | Hexokinase inhibitor | 0.141 0.09 CID_20662 | CID_20662 | |
| 0.08 | 0.122 | 0.167 | Beta amyloid protein antagonist | 0.167 0.03 CID_20662 | CID_20662 | |
| 0.069 | 0.113 | 0.089 | Alpha 2c adrenoreceptor antagonist | 0.089 0.076 CID_20662 | CID_20662 | |
| 0.047 | 0.094 | 0.066 | Protein kinase C beta inhibitor | 0.066 0.055 CID_20662 | CID_20662 | |
| 0.04 | 0.087 | 0.057 | Glucosylceramidase inhibitor | 0.057 0.034 CID_20662 | CID_20662 | |
| 0.067 | 0.115 | 0.085 | mTOR complex 2 inhibitor | 0.085 0.056 CID_20662 | CID_20662 | |
| 0.14 | 0.191 | 0.18 | DNA damaging | 0.18 0.134 CID_20662 | CID_20662 | |
| 0.022 | 0.075 | 0.036 | Ceramide glucosyltransferase inhibitor | 0.036 0.024 CID_20662 | CID_20662 | |
| 0.01 | 0.064 | 0.023 | Geranylgeranyltransferase I inhibitor | 0.023 0.013 CID_20662 | CID_20662 | |
| 0.046 | 0.105 | 0.067 | Interferon inducer | 0.067 0.04 CID_20662 | CID_20662 | |
| 0.056 | 0.115 | 0.085 | Acetylcholine agonist | 0.085 0.06 CID_20662 | CID_20662 | |
| 0.073 | 0.135 | 0.133 | Alkylator | 0.133 0.057 CID_20662 | CID_20662 | |
| 0.068 | 0.147 | 0.141 | AMP-activated protein kinase stimulant | 0.141 0.034 CID_20662 | CID_20662 | |
| 0.049 | 0.13 | 0.078 | Interferon agonist | 0.078 0.055 CID_20662 | CID_20662 | |
| 0.046 | 0.132 | 0.087 | Potassium channel (Ca-activated) activator | 0.087 0.068 CID_20662 | CID_20662 | |
| 0.025 | 0.111 | 0.055 | 5 Hydroxytryptamine 2 agonist | 0.055 0.033 CID_20662 | CID_20662 | |
| 0.012 | 0.112 | 0.039 | Glutamate (mGluR2) antagonist | 0.039 0.012 CID_20662 | CID_20662 | |
| 0.088 | 0.189 | 0.152 | DNA repair enzyme inhibitor | 0.152 0.029 CID_20662 | CID_20662 | |
| 0.015 | 0.127 | 0.051 | Glutamate (mGluR group II) antagonist | 0.051 0.015 CID_20662 | CID_20662 | |
| 0.033 | 0.152 | 0.111 | Leucine-rich repeat kinase 2 inhibitor | 0.111 0.036 CID_20662 | CID_20662 | |
| 0.053 | 0.26 | 0.106 | Nav1.5 sodium channel blocker | 0.106 0.074 CID_20662 | CID_20662 | |
| 0.005 | 0.307 | 0.023 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.023 0.006 CID_20662 | CID_20662 | |
| 0.019 | 0.453 | 0.159 | Acetylcholine M3 receptor agonist | 0.159 0.015 CID_20662 | CID_20662 | |
| 0.003 | 0.788 | 0.175 | Sigma receptor antagonist | 0.175 0.01 CID_20662 | CID_20662 | |
| 0.004 | 0.837 | 0.058 | 5 Hydroxytryptamine uptake inhibitor | 0.058 0.048 CID_20662 | CID_20662 | |
| 0.002 | 0.867 | 0.434 | Sigma 1 receptor antagonist | 0.434 0.004 CID_20662 | CID_20662 | |
| 0.004 | 0.905 | 0.227 | EphA2 antagonist | 0.227 0.009 CID_20662 | CID_20662 | |
| 0.004 | 0.914 | 0.088 | Antiadrenergic | 0.088 0.064 CID_20662 | CID_20662 | |
| 0.004 | 0.914 | 0.087 | Adrenaline antagonist | 0.087 0.062 CID_20662 | CID_20662 | |
| 0.012 | 0.996 | 0.32 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.32 0.018 CID_20662 | CID_20662 | |
| 0.004 | 0.995 | 0.129 | Phosphodiesterase VIII inhibitor | 0.129 0.004 CID_20662 | CID_20662 | |
| 0.004 | 0.996 | 0.048 | Factor IXa inhibitor | 0.048 0.04 CID_20662 | CID_20662 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |